Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues
about
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4Versican and the control of inflammation.The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.Versican facilitates chondrocyte differentiation and regulates joint morphogenesisRetrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients.Age-related differences in human skin proteoglycans.A role for versican in the development of leiomyosarcomaA new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican.Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory PhenotypesSelective activation of the versican promoter by epithelial- mesenchymal interactions during hair follicle developmentVersican: signaling to transcriptional control pathways.Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative ImmunohistochemistryAlternative splicing of the unique "PLUS" domain of chicken PG-M/versican is developmentally regulated.G1 Domain of Versican Regulates Hyaluronan Organization and the Phenotype of Cultured Human Dermal Fibroblasts.Hormone-regulated expression and distribution of versican in mouse uterine tissues.Nogo receptor homolog NgR2 expressed in sensory DRG neurons controls epidermal innervation by interaction with Versican.Expression of versican and ADAMTS1, 4, and 5 during bone development in the rat mandible and hind limb.Provisional matrix: A role for versican and hyaluronan.Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression.A Large Chondroitin Sulfate Proteoglycan, Versican, in Porcine Predentin.Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation.Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin.Versican G1 domain and V3 isoform overexpression results in increased chondrogenesis in the developing chick limb in ovo.Proteolytic cleavage of versican during limb joint development.Versican proteolysis mediates myocardial regression during outflow tract development.Inflammation amplification by Versican: the first mediator.Molecular cloning and characterization of chick sialoprotein associated with cones and rods, a developmentally regulated glycoprotein of interphotoreceptor matrix.Versican V2 is a major extracellular matrix component of the mature bovine brain.Proteolytic cleavage of versican during cardiac cushion morphogenesis.Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.The characterization of versican and its message in human articular cartilage and intervertebral disc.Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro.Molecular cloning and characterization of chick SPACRCAN.The gene structure and organization of mouse PG-M, a large chondroitin sulfate proteoglycan. Genomic background for the generation of multiple PG-M transcripts.Proteoglycan expression is influenced by mechanical load in TMJ discs.Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma.Versican V0 and V1 guide migratory neural crest cells.
P2860
Q28207975-0F585113-F076-4B12-81E8-A971E4863DC9Q33690423-AB7EAD2D-0F4A-44CF-986C-C22EA0B3D4A3Q33925634-FEC63172-A6ED-40E5-8329-A223FBCAF659Q33967118-42E1C771-BF16-4BE3-B260-13C4348FFCB5Q34286189-57B2E726-0E8F-4D0C-AC2D-55DF9C46EEDCQ34443319-14251792-92D3-4344-A616-1F40CC3E9B74Q34634226-7EBC4D03-B653-4431-9D1F-B61657C4D7B9Q35089330-34D0CBCB-CC3B-40B1-A9F0-7CF5477A4C35Q35618803-4795E66F-9F5A-4732-90C1-EE61A11673ACQ35795327-1ADC204E-1C74-4DBD-B006-8C4E1E753943Q36065126-41269B71-A7A0-445E-AF34-F2EE19AAFE2CQ36394907-5F68D85A-F82E-4270-BB0F-0EDEA570A7F4Q36538369-D23F42A3-7B2A-4B18-BED4-97B7B5DA2208Q36774513-2468FD90-C7F5-4FD8-BCFF-45238B32B9CFQ36851765-273284E0-C5C8-4A64-B1B2-EAB4F7481A50Q36954963-D5866372-B83A-488A-9782-A30C87F7F4A4Q37233620-CCFAC033-ACC9-4A47-868C-156BDADBC4F2Q37526070-2CE4765E-2DC7-49C0-A497-0C3A1788504BQ37643145-47E88A54-37B3-4B2C-B3D8-8C6C74A70808Q39033619-04533F85-F706-4F86-9A2C-1956EA2D0155Q39234675-0D3151FE-BDD7-45BE-BE78-356E5260B61FQ39985200-8A0C7C4E-A2B2-46D6-8ECB-21A2C7E685B4Q40304708-7AC42100-82BA-4A57-8155-5B00295E06EAQ40356687-227984BB-5D71-4B5C-BCEB-C13EE41A114DQ40957934-284A05E0-4C85-4606-B047-FED3B43AC8F5Q41783170-B6663327-185B-4B54-9D73-C7A4C609BB38Q41871512-9EDA03C6-4AF4-4357-98F0-435DDB3FD20BQ42079947-423DA92F-A950-4EE0-B163-245AB4EEB056Q42237876-45FF4F4F-82BB-441E-BFF5-612927A1708AQ42675603-64612CE0-CA29-4793-8BDA-DCF0492EC1FCQ42679048-4BAEFA81-9336-4F1F-92AE-5A4081529397Q42913840-1EF354DC-E557-4219-B41F-5430A671E5A7Q43864458-30AB1028-F523-4D49-8B1C-5B0E72F29FFBQ43936293-E6EAAF94-752B-4041-BA15-C0EB6ED875ECQ44131351-C5317ADE-AAC7-4822-BA75-1474B5540533Q46937305-BA2F7F17-903A-435B-9E57-29588EAFF780Q48074327-8CC5A377-D26B-4945-ACEB-AB451F963F2BQ50220949-D19670F9-ACC6-4EF5-9F36-762E0661EAB4Q54210708-2F8956E7-5D6D-45A7-8ADA-E0BCEF9C8BA3Q55470559-97A480C1-33C3-4833-9D76-6291FC4A1081
P2860
Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@ast
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@en
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@nl
type
label
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@ast
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@en
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@nl
prefLabel
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@ast
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@en
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@nl
P2093
P2860
P356
P1476
Expression of PG-M(V3), an alt ...... ion in mouse and human tissues
@en
P2093
P2860
P304
P356
10.1074/JBC.270.8.3914
P407
P577
1995-02-24T00:00:00Z